| SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus.
The fund is one of the largest investment funds in Scandinavia in the life science sector with approx.
€ 270 M (USD 325 M) under management.
The vision of SLS Venture is to become the leading Scandinavian life science investor with the aim of maximising return on investment by supporting small and mid-sized life science companies with a unique combination of capital, industrial and financial expertise.
The management team at SLS Venture has a strong industrial background and an extensive collective experience of research and development, company development and growth of small and large businesses.
|
SLS Venture believes that industrial experience and networks, that we bring to bare, are important when we, as a team, work with investments and are active owners in our portfolio companies. Experience, knowledge and understanding of the business environment surrounding a developing company are necessary and vital. Further, as international experience has shown, a strong local presence is key to success in the venture capital industry. Through our local offices we will not only generate a high quality deal flow but also be able to work closely with the portfolio companies and support them. Capital under management (aggregated funds) € 270 M (USD 325 M)
A strong Scandinavian investor base with
• Sixth Swedish National Pension Fund
• Danske Bank
• Innoventus Life Science KB
• Danica Pension
• Novo A/S
• Sparbanken Finn
• 23 portfolio companies
|
